SAB Biotherapeutics SABS SEC Filings

NASDAQ SABS
$3.72 +0.00 (+0.00%)
As of: Sep 4, 2026 · 2:18 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document SAB Biotherapeutics, Inc. (SABS) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index